CS logo
small CS logo
South Texas Research Institute

Edinburg, Texas, United States
Medical clinic in Edinburg, Texas
2502 W Trenton Rd, Edinburg, TX 78539

About South Texas Research Institute


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
Madrigal Pharmaceuticals, Inc.
3
Altimmune, Inc.
2
Hepion Pharmaceuticals, Inc.
2
Boehringer Ingelheim
1
Galectin Therapeutics Inc.
1
Genentech, Inc.
1
Gilead Sciences
1
Helio Genomics
1
Ionis Pharmaceuticals, Inc.
1
NorthSea Therapeutics B.V.
1
Sagimet Biosciences Inc.
1
Total Rows: 11

Clinical Trials at South Texas Research Institute


During the past decade, South Texas Research Institute conducted 15 clinical trials. In the 10-year time frame, 15 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 12 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years3322664400000000Started TrialsCompleted Trails201920202021202202468
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Phase 3 Study to Evaluate the Efficacy and Safety of MGL-3196 (Resmetirom) in Patients With NASH and Fibrosis
2019-03-28
2026-05-01
Recruiting
2,000
A Phase 2b Study of Icosabutate in Fatty Liver Disease
2019-07-17
2022-12-19
Completed
280
A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of BFKB8488A Compared With Placebo in Participants With Non-Alcoholic Steatohepatitis
2020-09-30
2023-01-23
Completed
46
A Phase 3 Study to Evaluate the Safety and Biomarkers of Resmetirom (MGL-3196) in Non Alcoholic Fatty Liver Disease (NAFLD) Patients
2019-12-16
2022-12-31
Active, not recruiting
1,400
Study Evaluating the Efficacy and Safety of Belapectin for the Prevention of Esophageal Varices in NASH Cirrhosis
2020-06-22
2024-12-01
Active, not recruiting
357
A Study to Test Safety and Efficacy of BI456906 in Adults With Non-alcoholic Steatohepatitis (NASH) and Fibrosis (F1-F3)
2021-04-27
2023-12-06
Active, not recruiting
295
Study of TVB-2640 in Subjects With Nonalcoholic Steatohepatitis (NASH)
2021-08-12
2023-09-28
Active, not recruiting
162
A Study to Assess the Safety, Efficacy, and Pharmacokinetics of Multiple Doses of ION224
2021-06-17
2024-03-01
Active, not recruiting
160

Rows per page:

1–15 of 15

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "South Texas Research Institute" #1 sponsor was "Madrigal Pharmaceuticals, Inc." with 3 trials, followed by "Altimmune, Inc." with 2 trials sponsored, "Hepion Pharmaceuticals, Inc." with 2 trials sponsored, "Boehringer Ingelheim" with 1 trials sponsored and "Galectin Therapeutics Inc." with 1 trials sponsored. Other sponsors include 1 different institutions and companies that sponsored additional 11 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "South Texas Research Institute" #1 collaborator was "Novo Nordisk A/S" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.
Created with Highcharts 11.1.0Top Leading SponsorsMadrigalPharmaceuticals, Inc.: 3MadrigalPharmaceuticals, Inc.: 3Altimmune, Inc.: 2Altimmune, Inc.: 2Hepion Pharmaceuticals, Inc.: 2Hepion Pharmaceuticals, Inc.: 2Boehringer Ingelheim: 1Boehringer Ingelheim: 1Galectin Therapeutics Inc.: 1Galectin Therapeutics Inc.: 1Genentech, Inc.: 1Genentech, Inc.: 1Gilead Sciences: 1Gilead Sciences: 1Helio Genomics: 1Helio Genomics: 1Ionis Pharmaceuticals, Inc.: 1Ionis Pharmaceuticals, Inc.: 1NorthSea Therapeutics B.V.: 1NorthSea Therapeutics B.V.: 1

Created with Highcharts 11.1.0Top CollaboratorsNovo Nordisk A/S: 1Novo Nordisk A/S: 1

Clinical Trials Conditions at South Texas Research Institute


According to Clinical.Site data, the most researched conditions in "South Texas Research Institute" are "Non-Alcoholic Fatty Liver Disease" (4 trials), "NASH - Nonalcoholic Steatohepatitis" (2 trials), "Cirrhosis" (1 trials), "Fibrosis, Liver" (1 trials) and "HCC" (1 trials). Many other conditions were trialed in "South Texas Research Institute" in a lesser frequency.

Clinical Trials Intervention Types at South Texas Research Institute


Most popular intervention types in "South Texas Research Institute" are "Drug" (14 trials), "Other" (4 trials) and "Diagnostic Test" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (11 trials), "ALT-801" (2 trials), "Resmetirom" (2 trials), "BFKB8488A" (1 trials) and "BI 456906" (1 trials). Other intervention names were less common.

Clinical Trials Genders at South Texas Research Institute


The vast majority of trials in "South Texas Research Institute" are 15 trials for "All" genders.

Clinical Trials Status at South Texas Research Institute


Currently, there are NaN active trials in "South Texas Research Institute". undefined are not yet recruiting, 5 are recruiting, 8 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in South Texas Research Institute, undefined suspended trials, and undefined terminated clinical trials to date.
Out of the total trials that were conducted in South Texas Research Institute, 2 "Phase 1" clinical trials were conducted, 9 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 2: 9Phase 2: 9Phase 3: 4Phase 3: 4Phase 1: 2Phase 1: 2

Created with Highcharts 11.1.0Trials StatusActive, not recruiting: 8Active, not recruiting: 8Recruiting: 5Recruiting: 5Completed: 2Completed: 2